Medico Intercontinental Limited has formally notified stock exchanges that it does not fall under the Large Corporate category as defined by SEBI's regulatory framework for debt securities fund raising. The company submitted this annual disclosure on April 8, 2026, to both BSE Limited and CSE-India as part of its regulatory compliance obligations.

SEBI Regulatory Framework Compliance

The disclosure was made pursuant to SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, which established specific guidelines for fund raising through debt securities by Large Corporates. This circular mandates particular disclosures and compliance requirements for entities classified as Large Corporates under the regulatory framework.

Exchange Notification Details

The company submitted identical notifications to both stock exchanges where its shares are listed:

Company Leadership Authorization

The disclosure was jointly signed by key company officials, demonstrating proper corporate governance protocols. Puneeta Sharma, Company Secretary & Compliance Officer, and Jay Sharadkumar Shah, Chief Financial Officer, both digitally signed the submission, ensuring authenticity and accountability.

Regulatory Significance

By confirming its non-classification as a Large Corporate, Medico Intercontinental Limited clarifies that it is not subject to the enhanced disclosure and compliance requirements that apply to larger entities under the SEBI framework. This classification affects the company's regulatory obligations when considering future debt securities issuance and related fund raising activities.

The company's proactive submission of this annual disclosure demonstrates its commitment to maintaining transparency with regulatory authorities and ensuring full compliance with applicable SEBI guidelines and exchange listing requirements.

Medico Intercontinental Limited has filed its quarterly confirmation certificate with BSE Limited, fulfilling regulatory compliance requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission, dated April 04, 2026, covers the company's dematerialization activities for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company submitted the mandatory Confirmation Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 to BSE Limited. Managing Director Samir D Shah signed the filing letter, which was addressed to the Listing Compliances department at BSE's P.J. Towers office in Mumbai.

Registrar Confirmation

Purva Sharegistry (India) Pvt. Ltd., serving as the company's registrar and transfer agent, provided the confirmation certificate dated April 01, 2026. The SEBI-registered entity (Registration No. INR000001112) confirmed compliance with dematerialization procedures and timelines as mandated under the regulations.

Ms. Deepali Gaonkar, Compliance Officer at Purva Sharegistry, signed the confirmation certificate. The registrar confirmed that all security certificates received for dematerialization were properly processed, with appropriate entries made in the register of members within prescribed timelines.

Dematerialization Activity Report

The quarterly report revealed no dematerialization activity during the period from January 01, 2026 to March 31, 2026. The detailed breakdown shows:

Company Information

Medico Intercontinental Limited operates with CIN L24100GJ1984PLC111413 and maintains its registered office at Aditraj Arcade, Satellite, Ahmedabad. The company's shares trade on BSE under scrip code 539938 with the identifier MIL.

The filing demonstrates the company's adherence to SEBI's quarterly reporting requirements for depositories and participants, ensuring transparency in share dematerialization processes and maintaining compliance with securities market regulations.